Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.53 |
| ▸ | XIAP | P98170 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | GRB2 | P62993 | 1/20 | 0.40 |
| ▸ | DPP3 | Q9NY33 | 1/20 | 0.40 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630498 | 0.92 | CAPN1 (0.51) | CAPN1XIAPCTSBSLC6A2GRB2 | |
| SCHEMBL29630574 | 0.91 | CAPN1 (0.49) | CAPN1XIAPCTSBSLC6A2GRB2 | |
| SCHEMBL30441296 | 0.90 | XIAP (0.52) | CAPN1XIAPCTSBSLC6A2GRB2 | |
| SCHEMBL29530605 | 0.89 | XIAP (0.49) | CAPN1XIAPCTSBSLC6A2GRB2 | |
| SCHEMBL29434651 | 0.89 | CAPN1 (0.54) | CAPN1XIAPCTSBSLC6A2 | |
| SCHEMBL29679608 | 0.88 | CAPN1 (0.49) | CAPN1XIAPCTSBSLC6A2GRB2 | |
| SCHEMBL32689777 | 0.88 | CAPN1 (0.57) | CAPN1XIAPCTSBSLC6A2GRB2 | |
| SCHEMBL29530904 | 0.87 | XIAP (0.48) | CAPN1XIAPSLC6A2GRB2 | |
| SCHEMBL29530598 | 0.87 | XIAP (0.53) | CAPN1XIAPCTSBSLC6A2MLX | |
| SCHEMBL30123097 | 0.87 | ACE (0.49) | CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |